Purpose of the Study: With the influx of veterans entering older adulthood, it is increasingly important to understand risk factors for cognitive decline. Posttraumatic stress disorder (PTSD) and the metabolic syndrome (MetS) are highly prevalent in older veterans. Although both increase risk for cognitive decline and often co-occur, it is unclear how they may interact to negatively impact cognition. The aim of this cross-sectional study was to investigate associations among PTSD, MetS, and cognitive function in older veterans. We hypothesized that co-occurring PTSD and MetS would be associated with worse cognitive performance than seen in either illness alone. Design and Methods: Participants completed cognitive testing to assess processing speed, verbal memory, and executive function. Data from 204 male veterans aged 55-89 were analyzed with the use of hierarchical multiple regression models. Results: Veterans with MetS demonstrated poorer performance on tasks of executive function (response inhibition and cognitive set shifting) and immediate verbal memory regardless of PTSD status. There was an interaction between MetS and PTSD on delayed verbal memory, suggesting that the negative impact of MetS on verbal memory was only significant for veterans not classified as having PTSD. Implications: This is the first study to examine the impact of comorbid PTSD and MetS on cognition. The results suggest that MetS is associated with poorer verbal learning and executive functioning independent of PTSD. We discuss the necessity of monitoring cerebrovascular risk factors and providing early behavioral and/or pharmaceutical interventions to lessen the risk of cognitive decline in older age.
services (Hermes, Hoff, & Rosenheck, 2014) , and the lifetime incidence of PTSD is estimated to be as high as 30% in this demographic (Weiss et al., 1992) .
In addition to the significant negative impact on emotional health, PTSD also increases risk for a range of physical comorbidities including a constellation of cardiometabolic abnormalities that has been termed the MetS (Heppner et al., 2009 ). The MetS consists of a group of vascular risk factors that commonly occur together and increase risk for cardiovascular disease and Type II diabetes. To meet criteria for the MetS, an individual must have three or more of the following risk factors: (a) abdominal obesity; (b) elevated fasting glucose; (c) elevated triglycerides; (d) reduced high density lipoprotein cholesterol (HDL-C); and (e) elevated blood pressure (Alberti et al., 2009) . Recent MetS prevalence estimates from the National Health and Nutrition Examination Survey (NHANES) range between 34% and 39% for adults over the age of 20 (Ervin, 2009 ). Specific prevalence rates increase with age, with older adults (aged 60+) more than four times more likely than young adults to meet criteria (Ervin, 2009) . In veterans specifically, one recent study reported that using a computer-based screening, 25% of veterans met criteria for MetS (Keane, Meier, Noth, & Swislocki, 2009) , and the authors discuss that the actual incidence of MetS is likely much higher than this estimate.
The exact mechanism connecting PTSD to the MetS remains unknown. However, it has been hypothesized that: (a) individuals with PTSD may be more prone to behaviors that contribute to the development of MetS including excessive alcohol use, smoking, increased caloric intake, inadequate physical exercise; (b) increased risk of developing MetS may be due to the side effects of secondgeneration antipsychotics; and finally (c) vascular and metabolic abnormalities may develop due to chronic stressrelated neuroendocrinal changes (Bartoli, Carrà, Crocamo, Carretta, & Clerici, 2013) .
PTSD and the MetS are both linked to accelerated cognitive aging. Having a past psychiatric history has been linked to cognitive decline in late life (Brown, 2010) , and veterans with a diagnosis of PTSD have a nearly twofold increased risk for developing dementia (Yaffe et al., 2010) . The strongest association between PTSD and cognitive difficulties is in the domain of complex attention (Qureshi et al., 2011) . Additional deficits in executive function, and memory above and beyond any attentional disturbance have also been reported (Brewin, Kleiner, Vasterling, & Field, 2007; Vasterling et al., 2002 ; see reviews by Moore, 2009 and Brailey, 2005) . Further, verbal memory appears to be impacted to a greater degree than visual memory (Brewin et al., 2007) . Research exploring the effect of PTSD on cognition is complicated by heterogeneity in sample characteristics, control groups, neuropsychological batteries, and comorbidities including the presence of cerebrovascular risk factors (CRFs; Cohen et al., 2013) .
Having MetS impacts brain health by increasing the risk for ischemic stroke, periventricular hyperintensities, and subcortical white matter lesions (Bokura, Yamaguchi, Iijima, Nagai, & Oguro, 2008; Kwon et al., 2006 Kwon et al., , 2009 Park et al., 2008) . Although some studies have found no significant links between MetS and cognition (Haley et al., 2010; Tournoy et al., 2010) , others have reported deficits across several domains including processing speed, executive function, memory, and overall intellectual functioning (Bokura, Nagai, Oguro, Kobayashi, & Yamaguchi, 2010; Cavalieri et al., 2010; Hassenstab, Sweat, Bruehl, & Convit, 2010; Komulainen et al., 2007; Segura et al., 2009) .
The impact of co-occurring PTSD and MetS on cognition is currently unknown. The aim of the current study was to investigate whether the presence of both conditions has an interactive or additive effect on cognitive performance (relative to the presence of PTSD or MetS alone). We examined this question in older veterans using a neuropsychological battery designed to test cognitive domains that are commonly affected by PTSD and CRFs (i.e., processing speed, executive function (complex attention and inhibition) and verbal memory). We hypothesized that cooccurring PTSD and MetS would be associated with worse cognitive performance than seen in either illness alone.
Design and Methods

Participants
A total of 204 male veterans were recruited via media advertisement, contact with local veteran agencies, and clinician referral from several clinics of the VA Palo Alto Health Care System (VAPAHCS). The sample consisted of primarily Vietnam Era veterans aged 55-89 years (M = 62.5, SD = 5.74) at the time of data collection. Veterans were recruited for the study from 2005 to 2013. Exclusionary criteria are listed in Table 1 . These criteria were established in order to rule out other identified risk factors for cognitive impairment (bipolar disorder, substance use disorders, recent head injury, and/or moderate to severe traumatic brain injury) and severe levels of cognitive impairment (i.e., dementia). Additionally, the current manuscript uses data from a larger study focused on longitudinal assessment of sleep disordered breathing in veterans, which is why the final criterion relates to current/previous treatment of obstructive sleep apnea (OSA).
Procedure
Informed consents, approved by Stanford University and VA Palo Alto Health Care System Institutional Review Boards, were obtained from all men. Participants were provided monetary compensation. Data collection took place at the Palo Alto campus of VAPAHCS. Participants completed detailed health questionnaires, including questions regarding treatment for hypertension, hyperlipidemia, and Type II diabetes mellitus. Blood samples were collected after a 12-hr fast to determine fasting blood glucose. A standardized cognitive test battery (see Cognitive Measures section) and the ClinicianAdministered PTSD Scale (CAPS) were administered by trained psychometrists.
PTSD Classification
The CAPS is a structured clinical interview that is designed to assess PTSD (DSM-IV) symptom presence and severity. In general, CAPS scores can be interpreted as follows: 0-19 = asymptomatic/few symptoms; 20-39 = mild PTSD/subthreshold; 40-59 = moderate PTSD/threshold; 60-79 = severe PTSD symptomatology; >80 = extreme PTSD symptomatology (Weathers, Keane, & Davidson, 2001 ). Veterans were classified as having PTSD if their CAPS (Blake et al., 1995) current and/or lifetime score (sum of frequency and intensity of symptoms) was ≥40, which is suggestive of at least moderate PTSD symptomatology.
The range and mean of scores for the entire sample were as follows: lifetime severity (range = 0-123, M = 57.4, SD = 38.1), current severity (range = 0-109, M = 31.7, SD = 27.5; Table 2 ).
MetS Classification
Classification for MetS was based upon the International Diabetes Federation criteria (Alberti et al., 2009) . A participant was classified as having MetS if he met three or more of the risk factors outlined in Table 3 . Measurements of waist circumference, body mass index (BMI; calculated from height and weight), systolic and diastolic blood pressure, and fasting glucose were also collected for all participants. Serum triglyceride and HDL-C levels were not available; therefore, one cholesterol criteria was met if participants were being treated for dyslipidemia (i.e., selfreported diagnosis or on medication for dyslipidemia; Table 3 ).
Cognitive Measures
Verbal Memory
The Rey Auditory Verbal Learning Test (RAVLT; Rey, 1964) was administered to assess verbal memory. The RAVLT requires participants to learn and recall 15 nouns presented verbally. The total words recalled during the five learning trials are summed and range from 0 to 75. The delay condition refers to the number of words recalled after a 20-min delay.
Executive Function
The Trail Making Test (TMT; Partington & Leiter, 1984) assesses executive function, set shifting, and processing speed and requires participants to connect numbers in ascending order (Part A) and switch between connecting numbers and letters (Part B). We subtracted the time to complete Part A from time to complete Part B (B − A) to control for differences in fine motor skills and psychomotor processing speed.
The Color-Word Interference Test (CWIT) from the DelisKaplan Executive Function System battery (Delis, Kaplan, & Kramer, 2003 ) is a measure of inhibition and set shifting. Participants are timed while naming colors (color naming condition), reading words (word reading condition), saying the ink color (inhibition condition), and switching between saying the ink color and reading the word (inhibition/switching condition). We subtracted the average of the color naming condition and the word reading condition from: (a) the inhibition condition, and (b) the inhibition/switching condition to isolate the executive function components of the tasks.
Processing Speed
Psychomotor processing speed was assessed using the Digit Symbol subtest of the Weschler Adult Intelligence Scale-III (Weschler, 1997) . The participant records the symbol (Folstein, Folstein, & McHugh, 1975 ) score <23) 6
Reported a history of seizure or other neurologic disorder or systemic illness affecting central nervous system function (chart review, interview) 7
Had an acute illness or unstable chronic illness (chart review, interview, basic blood chemistries) 8
Suffered a head injury within 1 year or had a history of loss of consciousness >24 hr 9
Used systemic steroid medication 10
Were consistently using continuous positive airway pressure for treatment of OSA or had corrective surgery for OSA (e.g., maxillary-mandibular advancement, uvulopalatopharyngoplasty, midline glossectomy, or lingualplasty)
Note: OSA = obstructive sleep apnea.
corresponding to each number as quickly as possible using a key of number-symbol pairs. The number of correct symbols recorded by the time limit is recorded as the score.
Data Analysis
Statistical analyses were performed using PASW statistical software package (PASW Statistics, Version 18). PTSD and MetS were dummy coded for easiest interpretation (0 = not meeting the classification; 1 = meeting the classification). Due to positively skewed distributions, log transformations were performed on CWIT inhibition/switching and TMT data. There were missing data for some of the cognitive measures: for two participants on CWIT, for three participants on RAVLT, and for five participants on the TMT.
Missing data were due to color blindness (CWIT), administrator errors and participant inability to complete the test. Missing data were omitted from the analyses. Two by two analyses of variance (ANOVAs) were used to determine if the groups differed on any demographic or health variables. Hierarchical regression analyses were used to investigate the main effects of PTSD, metabolic status, and the interactions between these two variables on cognitive performance with the effects of age and education removed. Covariates (age and education) were held constant on Level 1, PTSD and metabolic status were held constant on Level 2, and the PTSD by metabolic status interaction term was entered on Level 3.
Results
Demographic and Health Characteristics
Demographic and health characteristics of each group are presented in Table 2 . Approximately two-thirds of the sample was classified as having PTSD using the CAPS (PTSD+) and approximately half were classified as having the MetS (MetS+). Approximately 40% (N = 82) were classified as having both PTSD and MetS (PTSD+/MetS+). The majority of participants were Caucasian (62.2%) and the remaining participants identified as Hispanic or Latino (11.6%) African American (8.7%), Asian (2.9%), American Indian or Alaskan Native (2.4%), Native Hawaiian or Pacific Islander (1.9%), more than one race (6.8%), or unknown/not reported (3.4%).
Preliminary analyses (2 × 2 ANOVAs) were conducted to determine if there were group (PTSD+/PTSD− or MetS+/ a In the current sample, serum triglyceride and HDL-C levels were not available for the participants. Therefore, one of the cholesterol criteria was met if participants were being treated for dyslipidemia (i.e., self-reported diagnosis or on medication for dyslipidemia). 
Cognitive Performance
We report cognitive performance on our measures of interest in Table 2 , correlations among variables in Table 4 , and the results of multiple regression analyses are presented in Table 5 . On the RAVLT Learning Trials (Trials 1-5), the model containing age, education, PTSD, and MetS explained a significant amount of variance, F(4, 196) = 4.23, p = .003, R 2 = .061. After controlling for age and education, only MetS (β = 1.20, p = .002) was directly associated with performance ( Figure 1) . Specifically, having the MetS was associated with learning fewer words on this task. There was no significant direct effect of PTSD or PTSD by MetS interaction on RAVLT Trials 1-5 (ps > .05).
Similar to the learning trials, after controlling for covariates, the model containing age, education, PTSD, and MetS explained a significant amount of variance in word recall after a 20-min delay, F(4, 196) = 2.53, p = .04, R 2 = .05. Again, MetS was directly associated with word recall after a 20-minute delay (β = −.17, p = .01). Specifically, when controlling for age and education, and collapsing over PTSD group, MetS was predictive of recalling fewer words after a delay. This effect, however, was qualified by a significant PTSD by MetS interaction (β = .33, p = .02, ΔR 2 = .025) on predicting word recall (Figure 2) .
The Johnson-Neyman technique and tests of regions of significance (Hayes & Matthes, 2009) , were used to follow up on the interaction and determine if the effect of MetS was significant for veterans with and without PTSD (Figure 2) . Based on the model, the age and education corrected predicted means for each group are as follows: PTSD+ group recalled fewer words after a delay (b = −1.27, p = .03) than the PTSD− group. However, in the MetS− group PTSD status did not affect recall (b = −.58, p = .35; Figure 2 ). On the divided attention component of the Trail Making Test (Part B-A), the model containing age, education, PTSD and MetS accounted for a significant amount of variance F(4, 194) = 5.66, p < .001, R 2 = .086. After controlling for age, education and PTSD, MetS (β = .23, p = .001) again predicted poorer performance (a longer time to completion; Figure 3) , while the direct effect of PTSD approached significance (β = .14, p = .068).
The model containing age, education, PTSD and MetS also accounted for a significant amount of variance on the DKEFS Color-Word Interference Inhibition Condition F(4, 197) = 4.75, p = .001, R 2 = .069. The main effect of MetS was significant; specifically MetS was associated with a poorer performance (slower time) on this task (β = .20, p = .004; Figure 3 ). On the Inhibition/Switching condition of the CWIT, there were no significant direct effects of PTSD or MetS, or interaction between the two predicting performance, (ps > .05). A similar pattern of results was seen on the Digit Symbol measure, such that there was no significant effect of PTSD (β = −.13, p = .078), MetS (β = −.11, p = .098), or interaction between the two (β = .06, p = .69) on performance. There was no direct effect of PTSD or MetS by PTSD interaction on TMT B-A, CWIT Inhibition performance, or Digit Symbol (ps > .05). 
Discussion
Although PTSD and MetS have both been identified as risk factors for cognitive impairment in veterans (Veitch, Friedl, & Weiner, 2013) , to our knowledge, this is the first study to examine the independent and interactive effects of these conditions on cognition in older veterans. In this sample, meeting criteria for MetS was associated with poorer performance on verbal learning and executive function after controlling for age, education, and PTSD. Previous work by our group has linked obesity-related comorbidities (i.e., hypertension, diabetes) to poorer performance on verbal learning and executive function tasks. In that work, BMI was not independently predictive of cognitive performance, yet comorbid conditions that are included in the MetS classification (and were significantly associated with obesity) were related to cognition (Yesavage et al., 2014) . Our current findings are consistent with a number of previous studies linking the presence of CRFs to slowed processing speed, and poorer performance on tasks of verbal learning and executive function (Cavalieri et al., 2010; Dik et al., 2007; Hassenstab et al., 2010; Segura et al., 2009) .
In contrast to our hypothesis, the PTSD+/MetS+ veterans did not perform significantly worse than the groups only meeting criteria for one condition on any cognitive measure. Thus, there does not appear to be an additive effect of meeting criteria for PTSD and MetS on processing speed, verbal memory, or executive functioning. Interestingly, when the effect of MetS was removed, PTSD did not significantly impact cognitive performance.
The relationship between PTSD and cognitive function in veterans may be at least partially mediated by vascular risk factors, such as those included in the MetS classification (Cohen et al., 2013) . Older adults have higher base rates of MetS than young and middle-aged adults (Ervin, 2009 ). Thus, it is possible that some of the cognitive difficulties encountered by older veterans with PTSD relate to the presence of CRFs (Yaffe, Hoang, Byers, Barnes, & Friedl, 2014) , and it will be important for future studies to continue to include CRFs when examining relationships between PTSD and cognitive function.
There was a PTSD by MetS interaction on verbal memory such that the negative impact of MetS on verbal memory was only significant for PTSD− veterans (this could also be interpreted as the effect of PTSD was only significant for MetS+ veterans). In other words, the PTSD−/MetS+ group recalled the fewest words after a delay, even compared to the PTSD+/MetS+ group. Further, differences in CRFs did not account for this finding, as the only significant difference between the PTSD−/MetS+ and PTSD+/MetS+ group on health measures was greater systolic blood pressure in the PTSD+/MetS+ group.
We did not have information regarding how long each veteran met criteria for the MetS, and this may be an important factor in explaining this finding. There is evidence that the duration one has the MetS plays a crucial role in late life brain health. The presence of midlife vascular risk factors has been linked to structural abnormalities, cognitive decline, and increased risk of dementia in late life (Carmelli et al., 1999; Kivipelto et al., 2001; Solomon, Kivipelto, Wolozin, Zhou, & Whitmer, 2009; Whitmer, Sidney, Selby, Johnston, & Yaffe, 2005) . Interestingly, development of the MetS later in life (>75 years of age) may in fact, be protective against dementia (Forti et al., 2010) . In fact, blood pressure is lower in individuals with dementia (Guo, Viitanen, Fratiglioni, & Winblad, 1996; Molander, Gustafson, & Lövheim, 2010b) and tends to decrease during the years prior to the diagnosis (Molander, Gustafson, & Lovheim, 2010a; Qiu, von Strauss, Winblad, & Fratiglioni, 2004) . Although the exact mechanism is not currently known, it has been hypothesized that small vessel lesions, silent stroke, cerebral atrophy, and athererosclerosis may mediate the relationship between midlife vascular risk factors and cognitive decline. In late life, low blood pressure may be linked to cognitive decline via cerebral hypoperfusion, cerebral hypoxia, and ischemic injuries (Qiu, Winblad, & Fratiglioni, 2005) . It will be important for future research to determine at what point individuals developed the MetS and include this in predictive models.
Elevated inflammation (measured using serum levels of interleukin 6, C-reactive protein, and alpha 1-antichymotrypsin) in combination with the MetS is associated with increased risk for cognitive decline (Dik et al., 2007; Yaffe et al., 2004) . The relationship between inflammation and MetS is currently a topic of debate. For example, it has been suggested that inflammation may be a causal factor in developing MetS and possibly represents the link between obesity and development of cardiovascular disease (Das, 2002) . In contrast, Yaffe and colleagues (2004) discuss that having a genetic predisposition to a heightened inflammatory response may predispose individuals with MetS to greater cognitive impairment. As measures of inflammation were not included in the current study, it is unknown if the PTSD−/MetS+ and PTSD+/MetS+ groups differed with regard to inflammatory markers.
These results add to the existing literature and provide further evidence of the negative impact of MetS on cognitive function in older veterans with and without PTSD. Given that as many as 43% of veterans with PTSD may have the MetS (Heppner et al., 2009) , and the presence of CRFs involved in the MetS classification increases risk for cognitive decline (Whitmer et al., 2005; Yaffe et al., 2004) , midlife monitoring of weight gain, blood pressure, lipids, and fasting glucose in this population is crucial. There are multiple efficacious behavioral (diet, exercise) and pharmaceutical interventions that can be employed to control vascular and metabolic abnormalities in at-risk veterans (Chase, in press) , and taking part in productive activities (e.g., volunteering) may reduce inflammation (Kim & Ferraro, 2014) . Given that controlling vascular risk factors during mid-life may offset the deleterious effects on brain health in late life, monitoring and intervening when appropriate may reduce the risk of cognitive decline in veterans with PTSD.
This study has limitations that merit discussion. PTSD+ veterans were on average, 5 years younger with approximately 2 less years of education than PTSD− veterans though we controlled for this in the regression models by including age and education as covariates. Additionally, the PTSD+ group was recruited from 2005 to 2011 and the PTSD− group was recruited from 2010 to 2013. Our comparison groups (PTSD−/MetS−, PTSD+/MetS−), while not meeting criteria for MetS, were not completely free of CRFs. Using comparison groups that are free of vascular risk factors would be ideal to isolate the effect of MetS on cognitive function, however, a comparison group of that sort is not reflective of aging veterans. Of note, by excluding participants with current substance abuse/dependence and a recent head injury or history of severe traumatic brain injury, it is possible that this sample was selectively biased toward higher functioning veterans (i.e., veterans who may be healthier overall, have better coping skills, and have less debilitating PTSD symptomatology). Additionally, this may partially explain why we did not note a relationship between PTSD status and cognitive function.
We did not have data about the length of time participants met criteria for MetS, although in light of the reported links between midlife CRFs and late life cognitive decline and dementia, it is important that future studies collect this information. Finally, it is important to note that these analyses are cross sectional. Future studies should use longitudinal models to investigate the effect of MetS and PTSD on cognition.
In summary, we used a cross-sectional design to investigate the relationship between cognition, MetS and PTSD. Consistent with previous research, MetS was associated with poorer verbal learning and executive functioning. MetS was also associated with poorer short-term memory (fewer words recalled after a delay) in veterans not classified as having PTSD. Given the high prevalence of MetS in veterans, it may represent a clinically significant target of intervention for veterans at-risk for cognitive impairment. 
